Xencor, Inc. (XNCR) News

Latest headlines that mention XNCR, newest first · each headline opens the original publisher

XNCR quote

Last price: $35.03
Day change: +14.33%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

XNCR headlines

last 30 days

Seeking Alpha 9h ago

Xencor GAAP EPS of $0.50 beats by $0.83, revenue of $116.52M beats by $53.53M

Earnings T2XNCR

Seeking Alpha News 8d ago

Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma - Slideshow

General T2XNCR

Seeking Alpha 9d ago

Xencor soars 16% on encouraging early XmAb819 data

General T2XNCR

Seeking Alpha News 9d ago

Xencor: 'Strong Buy' On Positive XmAb819 ESMO Data ccRCC And Potential For FDA Accelerated Approval Pathway

General T2XNCR

Seeking Alpha News 9d ago

Xencor, Inc. (XNCR) Discusses Phase 1 XmAb819 Results in Advanced Clear Cell Renal Cell Carcinoma Transcript

General T2XNCR

Investing.com 9d ago

Xencor stock surges on positive cancer drug trial data

General T3XNCR

IBD 9d ago

Xencor Catapults On 'Unprecedented,' 'Profound' Cancer Data

Xencor stock catapulted Monday to a nearly four-year high, briefly breaking out on positive results in kidney cancer. The post Xencor Catapults On 'Unprecedented,' 'Profound' Cancer Data appeared first on Investor's Business Daily .

General T2XNCR

Seeking Alpha 10d ago

Xencor reports promising kidney cancer drug results, plans late-stage trial

General T2XNCR

Investing.com 10d ago

Xencor reports phase 1 data for cancer drug XmAb819

General T3XNCR

Seeking Alpha News 28d ago

Xencor: Better Funding For Obexelimab

General T2XNCR

XNCR news alerts

Get an alert by email or push when a new headline mentions XNCR.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.